he World Health Organization (WHO) has approved the use of the MVA-BN vaccine to prevent monkeypox, which can be administered in two doses four weeks apart to people aged 18 years and older.

The approval is expected to facilitate access to the vaccine in areas where the disease is endemic, with the goal of limiting the spread of the disease and containing outbreaks.

On August 14, the World Health Organization declared the monkeypox virus a public health emergency of international concern.